Chaparral Labs
back to search

protein

Acetoacetyl-CoA synthetase

AACS
protein:Q86V21disease:adad:direction:down

Gene

AACS

Organism

Homo sapiens(9606)

Length

672 aa

Mass

75,144 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

Acetoacetyl-CoA synthetase (AACS) is a cytosolic enzyme that converts acetoacetate to acetoacetyl-CoA, catalyzing a key step in ketone body utilization and supporting the biosynthesis of cholesterol and fatty acids (UniProt: Q86V21). The protein localizes to the cytoplasm and participates in metabolic pathways essential for cellular energy metabolism and lipid homeostasis. No baseline disease associations are documented in UniProt for this protein.

AACS is relevant to Alzheimer's Disease based on proteomics evidence from post-mortem AD brain tissue. Analysis of human AD brain versus age-matched controls using tandem mass tag (TMT) labeling and data-dependent acquisition (DDA) mass spectrometry across four subcellular fractions (P2, P3, S2, S3) showed that AACS is consistently downregulated in AD (mean log2 fold-change: −0.27; Chaparral AD proteomics). This reduction in ketone body-metabolizing capacity may reflect disrupted energy metabolism in Alzheimer's pathology, potentially contributing to mitochondrial dysfunction and impaired neuronal bioenergetics observed in the disease.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↓ Down in AD

P3

-0.269

P2

not detected

S2

not detected

S3

not detected

Mean log₂FC across detected fractions: -0.2688 (1 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

Converts acetoacetate to acetoacetyl-CoA in the cytosol (By similarity). Ketone body-utilizing enzyme, responsible for the synthesis of cholesterol and fatty acids (By similarity)

Sources

Last updated 5/8/2026, 6:39:45 AM